et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update. Allergy 2008; 63 (Suppl. 86):8–160. , ,
Editorial Committee for PG-MARJ. Practical guideline for the management of allergic rhinitis in Japan, 6th edn. Tokyo: Life Science, 2008.
Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol 2004; 113:43–9. , , , , .
Iatrogenic Cushing's syndrome due to dexamethasone nasal drops. Am J Med 1985; 79:535–7. , .
Merits and demerits of steroid – different whole body and limited part administering. J Jpn Immunol Allergol Otolaryngol 2000; 18:6–11. .
Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 2008; 63:1292–300. , .
et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999; 104:123–33. , ,
et al. Expression of costimulatory CD80/CD86-CD28/CD152 molecules in nasal mucosa of patients with perennial rhinitis. Clin Exp Allergy 2001; 31:1242–9. , ,
et al. Differential role of CD80 and CD86 molecules in the induction and effector phases of allergic rhinitis in mice. Am J Respir Crit Care Med 2001; 164:1501–7. , ,
et al. An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol 2006; 118:1117–25. , ,
et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199:1567–75. , ,
A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 2008; 9:310–18. , , , .
et al. Interleukin-4 independent production of Th2 cytokines by nasal lymphocytes and nasal eosinophilia in murine allergic rhinitis. Allergy 2000; 55:723–31. , ,
Signals through CD40 play a critical role in the pathophysiology of Schistosoma mansoni egg antigen-induced allergic rhinitis in mice. Am J Rhinol 2006; 20:165–9. , , , , .
Acute regulation of tight junction ion selectivity in human airway epithelia. Proc Natl Acad Sci USA 2009; 106:3591–6. , , , .
et al. and CD11c-positive dendritic cells penetrate beyond well-developed epithelial tight junctions in human nasal mucosa of allergic rhinitis. J Histochem Cytochem 2005; 53:611–19. , ,
Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 2004; 114:S135–8. .
et al. CRTH2 plays an essential role in the pathophysiology of Cry j 1-induced pollinosis in mice. J Immunol 2008; 180:5680–8. , ,
et al. Vascular endothelial growth factor in allergen-induced nasal inflammation. Clin Exp Allergy 2009; 39:655–61. , ,
et al. Cytokine messenger RNA expression for IL-4, IL-4, IL-5, and granulocyte/macrophage colony stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148:2390–4. , ,
Eosinophil: biological properties and role in health and disease. Clin Exp Allergy 2008; 38:709–50. , , , , , .
Double-stranded RNA induces production of RANTES and IL-8 by human nasal fibroblasts. Clin Immunol 2006; 118:51–8. , , , .
Eosinophilic cationic protein and specific IgE in serum and nasal mucosa of patients with grass-pollen-allergic rhinitis and asthma. Allergy 2001; 56:231–6. , , , .
et al. TNF-alpha contributes to the development of allergic rhinitis in mice. J Allergy Clin Immunol 2003; 112:134–40. , ,
Pathophysiology of allergic rhinitis. Int Arch Allergy Immunol 1996; 110:207–18. , , , .
et al. Involvement of cysteinyl leukotriens in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs. Eur J Pharmacol 1999; 369:349–56. , ,
et al. Phenotypic alteration of neuropeptide-containing nerve fibers in seasonal intermittent allergic rhinitis. Clin Exp Allergy 2004; 34:1105–10. , ,
Substance P as a potent stimulator of sneeze responses in experimental allergic rhinitis of guinea pigs. Agents Actions 1992; 37:245–9. , .
et al. Important roles of tachykinines in the development of allergic nasal hyperresponsiveness in guinea-pigs. Clin Exp Allergy 2008; 39:138–46. , ,
Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med 1994; 149:1457–65. , , , , .
Induction of nasal hyper-responsiveness by allergen challenge in allergic rhinitis: the role of afferent and efferent nerves. Clin Exp Allergy 2005; 35:45–51. , , , .
Nerve growth factor localization in the nasal mucosa of patients with persistent allergic rhinitis. Allergy 2009; 64:112–17. , , , , .
The role of chemical mediators and mucosal hyperreactivity in nasal in nasal hypersecretion in nasal allergy. J Allergy Clin Immunol 1987; 79:620–7. , , , .
Nasal nitric oxide and nasal allergy. Allergy 2006; 61:665–70. , , , .
Nasal nitric oxide does not control basal nasal patency or acute congestion following allergen challenge in allergic rhinitis. Ann Otol Rhinol Laryngol 1999; 108:368–72. , , , , , .
Different mechanisms between thromboxane A2- and leukotriene D4-induced nasal blockage in guinea-pigs. Prostagalandins Other Lipid Mediat 2006; 80:144–54. , , , , .
et al. The nuclear receptor superfamily: the second decade. Cell 1995; 83:835–9. , ,
Chaperoning of glucocorticoid receptors. Handb Exp Pharmacol 2006; 172:111–38. , , , .
The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 2007; 274:2–12. , .
The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J Biol Chem 1999; 274:27857–66. , , , , .
et al. Microbial superantigens induce glucocorticoid receptor β and steroid resistance in a nasal explants model. Laryngoscope 2004; 114:887–92. , ,
Corticosteroid effects on cell signaling. Eur Respir J 2006; 27:413–26. .
CD163: a signal receptor scavenging haptoglobin–hemoglobin complex from plasma. Int J Biochem Cell Biol 2002; 34:309–14. , , .
Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol Metab 2006; 17:321–7. , .
et al. The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study. Mol Endocrinol 2002; 16:694–706. , ,
Dexamethasone inhibits maturation, cytokine production and Fc epsilon RI expression of human cord blood-derived mast cells. Clin Exp Allergy 2002; 32:906–13. , , , , , .
Glucocorticosteroids inhibit leukotriene production. Ann Allergy Asthma Immunol 1997; 78:497–505. , , , , .
An in vitro comparison of commonly used topical glucocotricoid preparations. J Allergy Clin Immunol 1999; 104:623–9. , , , .
Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge. Ann Allergy Asthma Immunol 2001; 86:433–8. , , , .
Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156:4422–8. , , , .
et al. Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy. Allergy 2001; 56:126–31. , ,
et al. Topical corticosteroid inhibits interleukin-4, -5, and -13 in nasal secretions following allergen challenge. Clin Exp Allergy 2005; 35:1608–14. , ,
Effects of pollen and nasal glucocorticoids on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis. Allergy 2007; 62:1007–13. , , , .
et al. Expression of epsilon germ-line transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997; 27:2599–906. , ,
Inhibition of GM-CSF secretion by topical corticosteroids and nedocromil sodium. A comparison study using nasal polyp epithelial cells. Respir Med 2000; 94:428–31. , , , , .
Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling. Int Arch Allergy Immunol 2002; 128:51–8. , , , , , .
Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro. Acta Otolaryngol 2004; 124:964–9. , , , , , .
Influence of fluticasone propionate on the production of vascular endothelial growth factor and basic fibroblast growth factor from nasal fibroblasts in vitro. In Vivo 2004; 18:767–70. , , , , , .
et al. Expression of adhesion molecules in cultured human nasal mucosal microvascular endothelial cells activated by interleukin-1 beta or tumor necrosis factor-alpha: effects of dexametasone. Int Arch Allergy Immunol 1998; 117:68–77. , ,
Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflamatory cytokine mRNA in nasal polyp disease. J Allergy Clin Immunol 1999; 103:79–87. , , , , .
Topical budesonide treatment reduces endothelial expression of intracellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps. Acta Otolaryngol 1999; 119:362–8. , , , .
Glucocorticoids may not inhibit plasma exudation by direct vascular antipermeability effects in human airways. Eur Respir J 1994; 7:1120–4. , , , , .
The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells. Immunol Rev 2006; 212:60–73. , , , , , .
Regulatory T cells and immune tolerance. Cell 2008; 133:775–87. , , , .
Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057–61. , , .
Regulatory T cells in bronchial asthma. Allergy 2009; 64:335–47. , , , .
Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004; 34:1364–72. , , , , , .
IL-10 and TGF-beta cooperate in the regulatory T cell responses to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33:1205–14. , , , , , , .
Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa. J Allergy Clin Immunol 2008; 121:1467–72. , , , .
et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114:1425–33. , ,
et al. Quantitative and functional impairment of pulmonary CD4+ CD25high regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007; 119:1258–66. , ,
et al. T regulatory cells (Tregs) are increased in nasal polyps (NP) after treatment with intranasal steroid. Clin Immunol 2008; 129:394–400. , ,
Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3+CD4+CD25+ T regulatory cell in vivo and enhances their capacity to suppress EAE. Eur J Immunol 2006; 36:2139–49. , , , , .
et al. Induction of antigen-specific regulatory T lymphocytes by human dendritic cell expressing glucocorticoid-induced leucin zipper. Blood 2007; 110:211–19. , ,
The safety of intranasal steroids. Otolaryngol Head Neck Surg 2003; 129:739–50. , , .
et al. No growth suppression in children treated with the maximum recommended dose of fluticosone propionate aqueous nasal spray for one year. Allergy Asthma Proc 2002; 23:407–13. , ,
et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Periatrics 2000; 105:e22. , ,
Bioavailability of flutiasone propionate and mometasone furoate aqueous nasal sprays. Eur J Clin Pharmacol 2004; 60:265–8. , , , , , .
Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis. Allergy Asthma Proc 2009; 30:84–94. , , , , .
CT assessment of the effect of fluticasone propionate aqueous nasal spray treatment on lower turbinate hypertrophy due to vasomotor rhinitis. Acta Otolaryngol 2006; 126:37–42. , , , , .
Oral methylprednisolone acetate (Medrol tablets) for seasonal allergic rhinitis: examination of dose and symptom response. J Clin Pharmacol 1993; 33:816–22. , , .
Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic–pituitary–adrenal axis. J Allergy Clin Immunol 1998; 102:191–7. , , , , , .
Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy. Allergy 2000; 55:11–15. , , .
Depot corticosteroid treatment for hay fever causing avascular necrosis of both hips. BMJ 2001; 322:1589–91. , .
et al. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 2004; 34:952–7. , ,
et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 2007; 62:1078–84. , ,
et al. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 2007; 119:1430–7. , ,
Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2008; 100:194–9. , , , , .
Relationship between allergic rhinitis, disturber cognitive functions and psychological wellbeing. Clin Exp Allergy 2002; 32:1310–15. , , .
et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case–control study. J Allergy Clin Immunol 2007; 120:381–7. , ,
Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wilcoxon Sleep and Respiratory Research Group. J Allergy Clin Immunol 1997; 99:S757–62. , , .
et al. Seasonal allergic rhinitis and anti-histamine effect on children's learning. Ann Allergy 1993; 71:121–6. , ,
How do topical nasal corticoids improve sleep and daytime somnolence in allergic rhinitis? J Allergy Clin Immunol 2005; 116:1264–6. , , .
Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticosone propionate. Allergy Asthma Proc 2007; 28:226–9. , .
Medication for allergic rhinitis. Otolaryngol Head Neck Surg 2004; 76:39–44. .
et al. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J Allergy Clin Immunol 1996; 98:724–31. , ,
Prophylactic treatment of Japanese cedar pollinosis with intranasal coriticosteroids. Prog Med 2005; 25:3195–9. .
et al. Evaluation of efficacy, safety and effects on rhinitis-specific QOL by fluticasone propionate in pediatric patients with seasonal allergic rhinitis. Allergol Immunol 2005; 12:318–31. , ,
Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc 2004; 1:247–54. , , .